Incidence, determinants, and prognostic implications of true pleomorphism of ventricular tachycardia in patients with implantable cardioverter- defribillators a substudy of the DATAS trial

Circulation: Arrhythmia and Electrophysiology

Volumn 4, Issue 1, 2011, Pages 33-42

  Hadid, Claudio ^a   Almendral, Jesus ^a   Ortiz, Mercedes ^a   OttoSchwab, Joerg ^b   Janko, Sabine ^c   Mischke, Karl ^d   Arribas, Fernando ^e   Wolpert, Christian ^f   Ricci, Renato ^g   Adragao, Pedro ^h   Cobo, Erik ⁱ   Navarro, Xavier ^j   Quesada, Aurelio ^k  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f UNIVERSITY OF MANNHEIM   (Germany)

^g SAN FILIPPO NERI HOSPITAL   (Italy)

^h HOSPITAL DE SANTA CRUZ   (Portugal)

ⁱ UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^j Medtronic Spain   (Spain)

^k HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

more..

Author keywords

Cardioverter defribillators implantable; Intracardiac electrogram; Mortality; Tachycardia ventricular

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC PATIENT; DEFIBRILLATOR; ELECTROCARDIOGRAPHY MONITORING; FEMALE; GENDER; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOMORPHIC HEART VENTRICLE TACHYCARDIA; MORTALITY; MULTIPLE MORPHOLOGY HEART VENTRICLE TACHYCARDIA; PLEOMORPHIC HEART VENTRICLE TACHYCARDIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FOLLOW UP; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA, VENTRICULAR;

EID: 79953804060     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.110.957068     Document Type: Article

References (41)

1. Sarter BH, Finkle JK, Gerszten RE, Buxton AE. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? J Am Coll Cardiol. 1996;28:122-129. (Pubitemid 26266631)
2. Raitt MH, Renfroe EG, Epstein AE, McAnulty JH, Mounsey P, Steinberg JS, Lancaster SE, Jadonath RL, Hallstrom AP. "Stable" ventricular tachycardia is not a benign rhythm: insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) registry. Circulation. 2001; 103:244-252. (Pubitemid 32095410)
3. Josephson ME, Horowitz LN, Farshidi A, Spielman SR, Michelson EL, Greenspan AM. Recurrent sustained ventricular tachycardia. 4. Pleo-morphism. Circulation. 1979;59:459-468. (Pubitemid 9129657)
4. Miller JM, Kienzle MG, Harken AH, Josephson ME. Morphologically distinct sustained ventricular tachycardias in coronary artery disease: significance and surgical results. J Am Coll Cardiol. 1984;4:1073-1079. (Pubitemid 15184181)
5. Wilber DJ, Davis MJ, Rosenbaum M, Ruskin JN, Garan H. Incidence and determinants of multiple morphologically distinct sustained ventricular tachycardias. J Am Coll Cardiol. 1987;10:583-591. (Pubitemid 17125627)
6. Buxton AE, Waxman HL, Marchlinski FE, Untereker WJ, Waspe LE, Josephson ME. Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias. Circulation. 1984;69:532-540. (Pubitemid 14192265)
7. Mitrani RD, Biblo LA, Carlson MD, Gatzoylis KA, Henthorn RW, Waldo AL. Multiple monomorphic ventricular tachycardia configurations predict failure of antiarrhythmic drug therapy guided by electrophysi-ologic study. J Am Coll Cardiol. 1993;22:1117-1122. (Pubitemid 23285764)
8. Della Bella P, Riva S, Fassini G, Giraldi F, Berti M, Klersy C, Trevisi N. Incidence and significance of pleomorphism in patients with postmyo-cardial infarction ventricular tachycardia. Acute and long-term outcome of radiofrequency catheter ablation. Eur Heart J. 2004;25:1127-1138. (Pubitemid 38834071)
9. Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins CH, Delacretaz E, Della Bella P, Hindricks G, Jaïs P, Josephson ME, Kautzner J, Kay GN, Kuck K, Lerman BB, Marchlinski F, Reddy V, Schalij M, Schilling R, Soejima K, Wilber D. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2009;6:886-933.
10. Trappe HJ, Brugada P, Talajic M, Lezaun R, Wellens HJ. Value of induction of pleomorphic ventricular tachycardia during programmed stimulation. Eur Heart J. 1989;10:133-141 (Pubitemid 19081858)
11. Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibril-lators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
12. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Meta-analysis of the implantable cardioverter-defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Eur Heart J. 2000;21: 2071-2078.
13. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933-1940. (Pubitemid 26428217)
14. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882-1890.
15. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883. (Pubitemid 34984635)
16. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. (Pubitemid 40110811)
17. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol. 2008;51:e1-e62.
18. Marchlinski FE, Zado ES, Callans DJ, Patel VV, Ashar MS, Hsia HH, Russo AM. Hybrid therapy for ventricular arrhythmia management. Cardiol Clin. 2000;18:391-406. (Pubitemid 30331655)
19. Almendral JM, Atienza F, Rojo JL, Everss E, Castilla L, Gonzalez-Torrecilla E, Arenal A, Ortiz M, Datino T, Fernandez-Aviles F. Spatial resolution of ICD electrograms to identify different sites of left ventricular impulses [abstract]. Eur Heart J. 2008;29:645.
20. Almendral J, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E, Navarro X, Quesada A. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. Europace. 2008;10:528-535. (Pubitemid 351775295)
21. Quesada A, Almendral J, Arribas F, Ricci R, Wolpert C, Adragao P, Cobo E, Navarro X; DATAS Investigators. The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator. Europace 2004;6:142-150. (Pubitemid 38950183)
22. Ricci RP, Quesada A, Almendral J, Arribas F, Wolpert C, Adragao P, Zoni-Berisso M, Navarro X, DeSanto T, Grammatico A, Santini M. Dual-chamber implantable cardioverter-defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial. Europace. 2009;11:587-593.
23. Kouakam C, Kacet S, Hazard J, Ferraci A, Mansour H, Defaye P, Davy J, Lambiez M. Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia. Europace. 2004;6:32-42. (Pubitemid 38949865)
24. Aliot E, Nitzsché R, Ripart A. Arrhythmia detection by dual-chamber implantable cardioverter-defibrillators. A review of current algorithms. Europace. 2004;6:273-286. (Pubitemid 38949780)
25. Glikson M, Swerdlow CD, Gurevitz OT, Daoud E, Shivkumar K, Wilkoff B, Shipman T, Friedman PA. Optimal combination of discriminators for differentiating ventricular from supraventricular tachycardia by dual-chamber defibrillators. J Cardiovasc Electrophysiol. 2005;16:732-739. (Pubitemid 40994606)
26. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Glikson M. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation. 2006;113:2871-2879. (Pubitemid 44297227)
27. Reisinger J, Shenasa M, Lubinski A, Hindricks G, Haverkamp W, Chen X, Breithardt G, Borggrefe M. Clinical implications of pleomorphic ventricular tachycardias on oral sotalol therapy. Eur Heart J. 1995;16: 377-382.
28. Yeh Y, Lin K, Luqman N, Sung RJ, Kuo C. Pleomorphic ventricular tachycardia: an uncommon presentation in idiopathic left ventricular tachycardia. Pacing Clin Electrophysiol. 2005;28:343-345. (Pubitemid 40604054)
29. Costeas C, Peters NS, Waldecker B, Ciaccio EJ, Wit AL, Coromilas J. Mechanisms causing sustained ventricular tachycardia with multiple QRS morphologies: results of mapping studies in the infarcted canine heart. Circulation. 1997;96:3721-3731. (Pubitemid 27513454)
30. Bertomeu-Gonzalez V, Ruiz-Granell R, García-Civera R, Morell-Cabedo S, Ferrero A. Syncopal monomorphic ventricular tachycardia with pleo-morphism, sensitive to antitachycardia pacing in a patient with Brugada syndrome. Europace. 2006;8:1048-1050. (Pubitemid 44896799)
31. Abello M, González-Zuelgaray J, López C, Labadet C. Initiation modes of spontaneous monomorphic ventricular tachycardia in patients with Chagas heart disease. Rev Esp Cardiol. 2008;61:487-493. (Pubitemid 351930600)
32. Villacastín J, Almendral J, Arenal A, Albertos J, Ormaetxe J, Peinado R, Bueno H, Merino JL, Pastor A, Medina O, Tercedor L, Jiménez F, Delcán JL. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation. 1996;93:753-762. (Pubitemid 26052462)
33. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017.
34. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ. Inappropriate implantable cardioverter-defibrillator shocks in MADIT-II: frequency, mechanisms, predictors and survival impact. J Am Coll Cardiol. 2008;51:1357-1365. (Pubitemid 351443082)
35. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter-defibrillator against amiodarone. Circulation. 2000;101:1297-1302. (Pubitemid 30158618)
36. Kuck KH, Cappato R, Siebels J, Rüppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748-754. (Pubitemid 30648765)
37. Dolack GL. Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial). Cardiac Arrest in Seattle, Conventional versus Amiodarone Drug Evaluation. Am J Cardiol. 1994;73:237-241.
38. Lessmeier TJ, Lehmann MH, Steinman RT, Fromm BS, Akhtar M, Calkins H, DiMarco JP, Epstein AE, Estes NA, Fogoros RN. Implantable cardioverter- defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation. Am Heart J. 1994;128:211-218. (Pubitemid 24259141)
39. Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol. 2008;19:720-724.
40. Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H. Clinical course and implantable cardioverter-defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol. 2005;16:1265-1270.
41. Pires LA, Sethuraman B, Guduguntla VD, Todd KM, Yamasaki H, Ravi S. Outcome of women versus men with ventricular tachyarrhythmias treated with the implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol. 2002;13:563-568. (Pubitemid 34615420)